Sullivan S, Hinchcliff K. Update on exercise-induced pulmonary hemorrhage. The Veterinary Clinics of North America. Equine Practice. April 2015, 31 (1): 187–198. PMID 25770069. doi:10.1016/j.cveq.2014.11.011.
Täger T, Fröhlich H, Seiz M, Katus HA, Frankenstein L. READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials. Heart Failure Reviews. July 2019, 24 (4): 461–472. PMID 30874955. S2CID 77394851. doi:10.1007/s10741-019-09771-8.
Miles JA, Hanumanthu BK, Patel K, Chen M, Siegel RM, Kokkinidis DG. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis. Journal of Cardiovascular Medicine. June 2019, 20 (6): 379–388. PMID 30950982. S2CID 96436158. doi:10.2459/JCM.0000000000000794.
Abraham B, Megaly M, Sous M, Fransawyalkomos M, Saad M, Fraser R, Topf J, Goldsmith S, Simegn M, Bart B, Azzo Z, Mesiha N, Sharma R. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. The American Journal of Cardiology. January 2020, 125 (1): 92–99. PMID 31699358. S2CID 207937875. doi:10.1016/j.amjcard.2019.09.039(English). 引文格式1维护:未识别语文类型 (link)
Khan WJ, Arriola-Montenegro J, Mutschler MS, Bensimhon D, Halmosi R, Toth K, Alexy T. A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide. Heart Failure Reviews. November 2023, 28 (6): 1315–1323. PMID 37439967. S2CID 259843357. doi:10.1007/s10741-023-10331-4.
Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. Journal of Critical Care. April 2014, 29 (2): 253–259. PMID 24268626. doi:10.1016/j.jcrc.2013.10.004.
Katta N, Balla S, Alpert MA. Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review. The American Journal of Medicine. July 2016, 129 (7): 753.e7–753.e11. PMID 26899752. doi:10.1016/j.amjmed.2016.01.037.
Favrelière S, Delaunay P, Lebreton JP, Rouby F, Atzenhoffer M, Lafay-Chebassier C, Pérault-Pochat MC. Drug-induced hearing loss: a case/non-case study in the French pharmacovigilance database. Fundamental & Clinical Pharmacology. June 2020, 34 (3): 397–407. PMID 31912913. S2CID 210087413. doi:10.1111/fcp.12533.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology. September 1996, 50 (3): 670–678. PMID 8794909. doi:10.1016/S0026-895X(25)09339-3.
Kelly MR, Cutler RE, Forrey AW, Kimpel BM. Pharmacokinetics of orally administered furosemide. Clinical Pharmacology and Therapeutics. February 1974, 15 (2): 178–186. PMID 4812154. S2CID 74223978. doi:10.1002/cpt1974152178.
Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA. Furosemide disposition in cirrhosis. Clinical Pharmacology and Therapeutics. June 1982, 31 (6): 719–725. PMID 7075120. S2CID 27659838. doi:10.1038/clpt.1982.101.
World Health Organization. The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. 2023. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Korpi ER, Kuner T, Seeburg PH, Lüddens H. Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol. Pharmacol. 1995, 47 (2): 283–9. PMID 7870036.
Sullivan S, Hinchcliff K. Update on exercise-induced pulmonary hemorrhage. The Veterinary Clinics of North America. Equine Practice. April 2015, 31 (1): 187–198. PMID 25770069. doi:10.1016/j.cveq.2014.11.011.
Täger T, Fröhlich H, Seiz M, Katus HA, Frankenstein L. READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials. Heart Failure Reviews. July 2019, 24 (4): 461–472. PMID 30874955. S2CID 77394851. doi:10.1007/s10741-019-09771-8.
Miles JA, Hanumanthu BK, Patel K, Chen M, Siegel RM, Kokkinidis DG. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis. Journal of Cardiovascular Medicine. June 2019, 20 (6): 379–388. PMID 30950982. S2CID 96436158. doi:10.2459/JCM.0000000000000794.
Abraham B, Megaly M, Sous M, Fransawyalkomos M, Saad M, Fraser R, Topf J, Goldsmith S, Simegn M, Bart B, Azzo Z, Mesiha N, Sharma R. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. The American Journal of Cardiology. January 2020, 125 (1): 92–99. PMID 31699358. S2CID 207937875. doi:10.1016/j.amjcard.2019.09.039(English). 引文格式1维护:未识别语文类型 (link)
Khan WJ, Arriola-Montenegro J, Mutschler MS, Bensimhon D, Halmosi R, Toth K, Alexy T. A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide. Heart Failure Reviews. November 2023, 28 (6): 1315–1323. PMID 37439967. S2CID 259843357. doi:10.1007/s10741-023-10331-4.
Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. Journal of Critical Care. April 2014, 29 (2): 253–259. PMID 24268626. doi:10.1016/j.jcrc.2013.10.004.
Katta N, Balla S, Alpert MA. Does Long-Term Furosemide Therapy Cause Thiamine Deficiency in Patients with Heart Failure? A Focused Review. The American Journal of Medicine. July 2016, 129 (7): 753.e7–753.e11. PMID 26899752. doi:10.1016/j.amjmed.2016.01.037.
Favrelière S, Delaunay P, Lebreton JP, Rouby F, Atzenhoffer M, Lafay-Chebassier C, Pérault-Pochat MC. Drug-induced hearing loss: a case/non-case study in the French pharmacovigilance database. Fundamental & Clinical Pharmacology. June 2020, 34 (3): 397–407. PMID 31912913. S2CID 210087413. doi:10.1111/fcp.12533.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology. September 1996, 50 (3): 670–678. PMID 8794909. doi:10.1016/S0026-895X(25)09339-3.
Kelly MR, Cutler RE, Forrey AW, Kimpel BM. Pharmacokinetics of orally administered furosemide. Clinical Pharmacology and Therapeutics. February 1974, 15 (2): 178–186. PMID 4812154. S2CID 74223978. doi:10.1002/cpt1974152178.
Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA. Furosemide disposition in cirrhosis. Clinical Pharmacology and Therapeutics. June 1982, 31 (6): 719–725. PMID 7075120. S2CID 27659838. doi:10.1038/clpt.1982.101.
Täger T, Fröhlich H, Seiz M, Katus HA, Frankenstein L. READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials. Heart Failure Reviews. July 2019, 24 (4): 461–472. PMID 30874955. S2CID 77394851. doi:10.1007/s10741-019-09771-8.
Miles JA, Hanumanthu BK, Patel K, Chen M, Siegel RM, Kokkinidis DG. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis. Journal of Cardiovascular Medicine. June 2019, 20 (6): 379–388. PMID 30950982. S2CID 96436158. doi:10.2459/JCM.0000000000000794.
Abraham B, Megaly M, Sous M, Fransawyalkomos M, Saad M, Fraser R, Topf J, Goldsmith S, Simegn M, Bart B, Azzo Z, Mesiha N, Sharma R. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. The American Journal of Cardiology. January 2020, 125 (1): 92–99. PMID 31699358. S2CID 207937875. doi:10.1016/j.amjcard.2019.09.039(English). 引文格式1维护:未识别语文类型 (link)
Favrelière S, Delaunay P, Lebreton JP, Rouby F, Atzenhoffer M, Lafay-Chebassier C, Pérault-Pochat MC. Drug-induced hearing loss: a case/non-case study in the French pharmacovigilance database. Fundamental & Clinical Pharmacology. June 2020, 34 (3): 397–407. PMID 31912913. S2CID 210087413. doi:10.1111/fcp.12533.
Kelly MR, Cutler RE, Forrey AW, Kimpel BM. Pharmacokinetics of orally administered furosemide. Clinical Pharmacology and Therapeutics. February 1974, 15 (2): 178–186. PMID 4812154. S2CID 74223978. doi:10.1002/cpt1974152178.
Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA. Furosemide disposition in cirrhosis. Clinical Pharmacology and Therapeutics. June 1982, 31 (6): 719–725. PMID 7075120. S2CID 27659838. doi:10.1038/clpt.1982.101.